Lee S Cohen

Array ( [id] => 6906214 [patent_doc_number] => 20050101609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Quinazoline derivatives as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/344736 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6923 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101609.pdf [firstpage_image] =>[orig_patent_app_number] => 10344736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 956288 [patent_doc_number] => 06956039 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-18 [patent_title] => 'Nitrogenous heterocylic compounds' [patent_app_type] => utility [patent_app_number] => 10/344737 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5686 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/956/06956039.pdf [firstpage_image] =>[orig_patent_app_number] => 10344737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1236498 [patent_doc_number] => 06689896 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-10 [patent_title] => 'Thyromimetic organic compounds' [patent_app_type] => B2 [patent_app_number] => 09/931683 [patent_app_country] => US [patent_app_date] => 2001-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12426 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689896.pdf [firstpage_image] =>[orig_patent_app_number] => 09931683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653371 [patent_doc_number] => 20030008885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Azolo triazines and pyrimidines' [patent_app_type] => new [patent_app_number] => 09/930782 [patent_app_country] => US [patent_app_date] => 2001-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47512 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008885.pdf [firstpage_image] =>[orig_patent_app_number] => 09930782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1270844 [patent_doc_number] => 06653305 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-25 [patent_title] => 'Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them' [patent_app_type] => B2 [patent_app_number] => 09/929931 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13071 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653305.pdf [firstpage_image] =>[orig_patent_app_number] => 09929931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7605314 [patent_doc_number] => 07115615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Quinazoline derivatives' [patent_app_type] => utility [patent_app_number] => 10/344678 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51109 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115615.pdf [firstpage_image] =>[orig_patent_app_number] => 10344678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033566 [patent_doc_number] => 20020019406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => '9H-pyrimido[4,5-b]indole derivatives: CRF1 specific ligands' [patent_app_type] => new [patent_app_number] => 09/930734 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8218 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019406.pdf [firstpage_image] =>[orig_patent_app_number] => 09930734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209815 [patent_doc_number] => 06713486 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof' [patent_app_type] => B1 [patent_app_number] => 09/913391 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12009 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713486.pdf [firstpage_image] =>[orig_patent_app_number] => 09913391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6210051 [patent_doc_number] => 20020072527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Polymorphs of zaleplon and methods for the preparation thereof' [patent_app_type] => new [patent_app_number] => 09/921017 [patent_app_country] => US [patent_app_date] => 2001-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6767 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072527.pdf [firstpage_image] =>[orig_patent_app_number] => 09921017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889164 [patent_doc_number] => 20020013310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds' [patent_app_type] => new [patent_app_number] => 09/918039 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72681 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013310.pdf [firstpage_image] =>[orig_patent_app_number] => 09918039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5802231 [patent_doc_number] => 20020010176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'Integrin receptor antagonists' [patent_app_type] => new [patent_app_number] => 09/916977 [patent_app_country] => US [patent_app_date] => 2001-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46807 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20020010176.pdf [firstpage_image] =>[orig_patent_app_number] => 09916977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048678 [patent_doc_number] => 20020169161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Potassium channel inhibitors' [patent_app_type] => new [patent_app_number] => 09/910818 [patent_app_country] => US [patent_app_date] => 2001-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14377 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169161.pdf [firstpage_image] =>[orig_patent_app_number] => 09910818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6345174 [patent_doc_number] => 20020035253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitors' [patent_app_type] => new [patent_app_number] => 09/909731 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9674 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20020035253.pdf [firstpage_image] =>[orig_patent_app_number] => 09909731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5845393 [patent_doc_number] => 20020132821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Novel heteroaryl derivatives and their use as medicaments' [patent_app_type] => new [patent_app_number] => 09/910142 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5817 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132821.pdf [firstpage_image] =>[orig_patent_app_number] => 09910142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097364 [patent_doc_number] => 20020052470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4' [patent_app_type] => new [patent_app_number] => 09/910702 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29293 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052470.pdf [firstpage_image] =>[orig_patent_app_number] => 09910702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096958 [patent_doc_number] => 20020052375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => '3-(Heteroaryal) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4' [patent_app_type] => new [patent_app_number] => 09/910466 [patent_app_country] => US [patent_app_date] => 2001-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29787 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052375.pdf [firstpage_image] =>[orig_patent_app_number] => 09910466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1326570 [patent_doc_number] => 06603000 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-05 [patent_title] => 'Synthesis for heteroarylamine compounds' [patent_app_type] => B2 [patent_app_number] => 09/902085 [patent_app_country] => US [patent_app_date] => 2001-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5407 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/603/06603000.pdf [firstpage_image] =>[orig_patent_app_number] => 09902085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 910420 [patent_doc_number] => 07329663 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-12 [patent_title] => 'Substituted-triazolopyrimidines as anticancer agents' [patent_app_type] => utility [patent_app_number] => 09/895975 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32612 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/329/07329663.pdf [firstpage_image] =>[orig_patent_app_number] => 09895975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1210129 [patent_doc_number] => 06713578 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-30 [patent_title] => 'Amine organoborane complex polymerization initiators and polymerizable compositions' [patent_app_type] => B2 [patent_app_number] => 09/881985 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10044 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 261 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713578.pdf [firstpage_image] =>[orig_patent_app_number] => 09881985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000820 [patent_doc_number] => 20020028894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Amine organoborane complex polymerization initiators and polymerizable compositions' [patent_app_type] => new [patent_app_number] => 09/881983 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10124 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028894.pdf [firstpage_image] =>[orig_patent_app_number] => 09881983 [rel_patent_id] =>[rel_patent_doc_number] =>)